Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Food Allergy Treatment Market Is Set to Triple — What it Means for Patients

Microbiome Therapies Show Potential in Food Allergy Research

Sublingual Epinephrine Advances as FDA Clarifies Requirements for Approval

Experimental KIC-IT Protocol Shows Early Success in Reversing Infant Food Allergies

Dupilumab Shows Promise for Patients Struggling With OIT Side Effects

Oral Immunotherapy: What You Should Know, and What’s New (Webinar)

Pending Litigation Shows Food Allergy Treatments in Development are Sometimes Overhyped

BlueWillow Completes Preclinical Studies of Intranasal Peanut Allergy Vaccine

FDA Has Questions About Viaskin Peanut Efficacy, Delays Meeting with DBV...

ARS to Present Data from Intranasal Epinephrine (ARS-1) Studies at AAAAI...

FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment...

Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development...

End Allergies Together Announces Winners of $1 Million Grand Challenge to...

FDA Opens Door for Clinical Development of Aquestive Therapeutics Anaphylaxis Treatment

Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development...

Your School On Our Map

Put Your School on the Map